Howe Jill Ann - Insider Non-Derivative Transactions at Lineage Cell Therapeutics, Inc. (LCTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 16, 2024, Howe Jill Ann's relationship to Lineage Cell Therapeutics, Inc. (LCTX) is Officer (Chief Financial Officer), and currently has 10,500 shares of Common Shares.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other LCTX insiders.
Data Source: SEC.
Howe Jill Ann - Insider Non-Derivative Transactions at LCTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 17, 2024 | P -- (Common Shares) | 10500 | 0.89 | 10500 |